UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study

Sangro, B; Yau, T; Hsu, C; Kudo, M; Crocenzi, TS; Choo, S-P; Meyer, T; ... Trojan, J; + view all (2017) Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study. Presented at: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS.

Full text not available from this repository.
Type: Conference item (UNSPECIFIED)
Title: Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study
Event: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver
Location: Amsterdam, NETHERLANDS
Dates: 19 April 2017 - 23 April 2017
DOI: 10.1016/S0168-8278(17)30329-X
Keywords: Science & Technology, Life Sciences & Biomedicine, Gastroenterology & Hepatology
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/1562637
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item